Juvenescence exercises 377,865 warrants at $13.20 for $4.99M; remaining due Nov 2024 & June 2025

Serina Therapeutics, Inc.

Juvenescence exercised 377,865 post-merger warrants at $13.20/share, generating $4,987,818 in proceeds.
Upon exercise, Juvenescence also received incentive warrants for 377,865 shares at $18.00, expiring March 26, 2028.
This exercise is one-third of total post-merger warrants; second third due by Nov 30, 2024, final third by June 30, 2025.
Proceeds will be used for general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.